Meta-analysis shows increased risk of psychosis in ADHD with stimulant treatment, highlighting concerns with amphetamines.
A systematic review and meta‐analysis encompassing 16 studies has found a non‐negligible occurrence of psychosis and bipolar disorder in individuals with attention‐deficit hyperactivity disorder (ADHD) who received stimulant treatment. Risk was higher with use of amphetamines compared with methylphenidate.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: